What is the current status of second-line chemotherapy for castration-resistant prostate cancer?
Rosenberg
Jonathan E
JE
Harvard Medical School, Lank Center for Genitourinary Oncology, Dana-Farber CancerInstitute, Boston, MA 02446, USA. jonathan_rosenberg@dfci.harvard.edu
Oh
William K
WK